Company Merck & Co., Inc.

MRK

US58933Y1055

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 10:37:31 2025-01-21 EST			5-day change	1st Jan Change
96.78 ^USD	-1.17%		-2.95%	-2.78%

09:06am	Morgan Stanley Adjusts Merck Price Target to $113 From $123, Maintains Equal Weight Rating	MT
01-17	Novo Nordisk's Ozempic, Wegovy Among Drugs Chosen for US Medicare Price Talks	MT

Business description: Merck & Co., Inc.

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (67%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (22.1%);

- sale of animal health products (9.4%);

- other (1.5%).

Net sales are distributed geographically as follows: the United States (47.4%), Europe/Middle East/Africa (22%), China (11.3%), Japan (5.3%), Asia/Pacific (5.4%), Latin America (5.1%) and other (3.5%).

Number of employees: 71,000

Sales by Activity: Merck & Co., Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
Pharmaceutical	41.75B	43.02B	42.75B	52B	53.58B
Animal Health	4.39B	4.7B	5.57B	5.55B	5.62B
Unallocated Other Revenues	521M	247M	382M	1.73B	907M
Other profits	175M	23M	-	-	-

See all business segments

Geographical breakdown of sales: Merck & Co., Inc.

Fiscal Period: December	2019	2020	2021	2022	2023
United States	20.32B	21.03B	22.42B	27.21B	28.48B
Europe, Middle East and Africa	12.71B	13.6B	13.34B	14.49B	13.25B
China	3.21B	3.62B	4.38B	5.19B	6.8B
Asia Pacific (other than China and Japan)	2.94B	2.86B	2.41B	3.61B	3.22B
Japan	3.58B	3.38B	2.73B	3.63B	3.16B
Latin America	2.47B	2.27B	2.21B	2.58B	3.09B
Other	1.61B	1.23B	1.22B	2.57B	2.1B

See all geographic segments

Managers: Merck & Co., Inc.

Director	Title	Age	Since
Robert Davis CEO	Chief Executive Officer	58	2021-06-30
Caroline Litchfield DFI	Director of Finance/CFO	56	2021-03-31
Dave Williams CTO	Chief Tech/Sci/R&D Officer	56	2020-07-31
Joseph Romanelli IRC	Investor Relations Contact	51	1995-12-31
Peter Dannenbaum IRC	Investor Relations Contact	-	2017-06-30

See MERCK & CO., INC. governance

Members of the board: Merck & Co., Inc.

Manager	Title	Age	Since
Tom Glocer BRD	Director/Board Member	64	2007-11-26
Patricia Russo BRD	Director/Board Member	72	1995-08-31
Robert Davis CHM	Chairman	58	2022-11-30
Pamela Craig BRD	Director/Board Member	68	2015-08-31
Paul Rothman BRD	Director/Board Member	66	2015-08-31
Inge Thulin BRD	Director/Board Member	70	2018-02-28
Mary Coe BRD	Director/Board Member	58	2019-03-17
Kathy Warden BRD	Director/Board Member	53	2020-03-15
Christine Seidman BRD	Director/Board Member	72	2020-03-15
Risa Lavizzo-Mourey BRD	Director/Board Member	70	2020-05-25

Composition of the Board of Directors

Shareholders: Merck & Co., Inc.

Name	Equities	%	Valuation
Vanguard Fiduciary Trust Co. 9.875 %	249,803,915	9.875 %	24 850 M $
BlackRock Advisors LLC 6.312 %	159,673,461	6.312 %	15 884 M $
STATE STREET CORPORATION 4.705 %	119,026,412	4.705 %	11 841 M $
Wellington Trust Co., NA 2.997 %	75,809,383	2.997 %	7 542 M $
Geode Capital Management LLC 2.338 %	59,155,004	2.338 %	5 885 M $

Name	Equities	%	Valuation
Caixa DTVM SA 0.001356 %	274,370	0.001356 %	3 M $
Safra Asset Management Ltda. 0.000248 %	50,200	0.000248 %	613 667 $
BRAM - Bradesco Asset Management SA DTVM 0.000215 %	43,462	0.000215 %	531 299 $
XP Allocation Asset Management Ltda. 0.000069 %	13,916	0.000069 %	170 115 $

List of MERCK & CO., INC. shareholders

Holdings: Merck & Co., Inc.

Name	Equities	%	Valuation
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. 10.23%	13,443,693	10.23%	282,617,078 $
PERSONALIS, INC. 19.78%	14,044,943	19.78%	81,179,771 $
ENTRADA THERAPEUTICS, INC. 4.65%	1,739,768	4.65%	30,080,589 $

Company details: Merck & Co., Inc.

Merck & Co., Inc.

126 East Lincoln Avenue

07065, Rahway

+908 740 4000

http://www.merck.com

Group companies: Merck & Co., Inc.

Name	Category and Sector
Organon (India) Pvt Ltd. Organon (India) Pvt Ltd. Pharmaceuticals: MajorHealth Technology Organon India Pvt Ltd. manufactures and distribution of pharmaceutical preparations. The company is headquartered in Mumbai, India.	Pharmaceuticals: Major
Organon LLC
Merck International Holdings LLC
Merck Holdings, Inc.
Merck Sharp & Dohme Manufacturing Unlimited Co.

See all subsidiaries

Other Pharmaceuticals

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
MERCK & CO., INC.	-1.17%	-2.95%	-19.02%	+20.92%	248B
ELI LILLY AND COMPANY	+0.56%	-1.92%	+15.81%	+200.59%	653B
JOHNSON & JOHNSON	+0.60%	+2.27%	-8.89%	-10.21%	354B
NOVO NORDISK A/S	+4.23%	-3.11%	-21.02%	+81.82%	341B
ABBVIE INC.	+0.60%	-1.59%	+4.46%	+30.90%	303B
ROCHE HOLDING AG	+0.64%	+2.09%	+8.51%	-25.44%	236B
ASTRAZENECA PLC	+1.94%	+3.46%	+3.85%	+25.66%	206B
NOVARTIS AG	+0.20%	-0.70%	-5.21%	+12.03%	197B
PFIZER, INC.	+0.89%	+0.28%	-6.45%	-49.83%	149B
AMGEN INC.	+0.02%	+1.99%	-12.17%	+19.63%	146B
Average	+0.84%	-1.83%	-4.01%	+30.61%	283.38B
Weighted average by Cap.	+0.92%	-3.21%	-1.52%	+58.94%